Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis

David Garate; Christopher J. Thang; Crystal T. Chang; Shayan Owji; Trevor L. Murphy; George Golovko; Joel Correa Da Rosa; Emma Guttman-Yassky; Michael G. Wilkerson; Nicholas Gulati

doi:10.1016/j.jaip.2024.11.015

Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis

David Garate
, Christopher J. Thang
, Crystal T. Chang
, Shayan Owji
, Trevor L. Murphy
, George Golovko
, Joel Correa Da Rosa
, Emma Guttman-Yassky
, Michael G. Wilkerson
, Nicholas Gulati

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	698-701.e1
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	13
Issue number	3
DOIs	https://doi.org/10.1016/j.jaip.2024.11.015
State	Published - Mar 2025

ASJC Scopus subject areas

Immunology and Allergy

Access to Document

10.1016/j.jaip.2024.11.015

Cite this

Garate, D., Thang, C. J., Chang, C. T., Owji, S., Murphy, T. L., Golovko, G., Da Rosa, J. C., Guttman-Yassky, E., Wilkerson, M. G., & Gulati, N. (2025). Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis. Journal of Allergy and Clinical Immunology: In Practice, 13(3), 698-701.e1. https://doi.org/10.1016/j.jaip.2024.11.015

Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis. / Garate, David; Thang, Christopher J.; Chang, Crystal T. et al.
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 13, No. 3, 03.2025, p. 698-701.e1.

Research output: Contribution to journal › Article › peer-review

Garate, D, Thang, CJ, Chang, CT, Owji, S, Murphy, TL, Golovko, G, Da Rosa, JC, Guttman-Yassky, E, Wilkerson, MG & Gulati, N 2025, 'Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis', Journal of Allergy and Clinical Immunology: In Practice, vol. 13, no. 3, pp. 698-701.e1. https://doi.org/10.1016/j.jaip.2024.11.015

@article{74caef9bfd724d428a91541d93bb484b,

title = "Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis",

author = "David Garate and Thang, \{Christopher J.\} and Chang, \{Crystal T.\} and Shayan Owji and Murphy, \{Trevor L.\} and George Golovko and \{Da Rosa\}, \{Joel Correa\} and Emma Guttman-Yassky and Wilkerson, \{Michael G.\} and Nicholas Gulati",

year = "2025",

month = mar,

doi = "10.1016/j.jaip.2024.11.015",

language = "English (US)",

volume = "13",

pages = "698--701.e1",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "3",

}

TY - JOUR

T1 - Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients

T2 - A national database analysis

AU - Garate, David

AU - Thang, Christopher J.

AU - Chang, Crystal T.

AU - Owji, Shayan

AU - Murphy, Trevor L.

AU - Golovko, George

AU - Da Rosa, Joel Correa

AU - Guttman-Yassky, Emma

AU - Wilkerson, Michael G.

AU - Gulati, Nicholas

PY - 2025/3

Y1 - 2025/3

UR - https://www.scopus.com/pages/publications/85212322461

UR - https://www.scopus.com/pages/publications/85212322461#tab=citedBy

U2 - 10.1016/j.jaip.2024.11.015

DO - 10.1016/j.jaip.2024.11.015

M3 - Article

C2 - 39613098

AN - SCOPUS:85212322461

SN - 2213-2198

VL - 13

SP - 698-701.e1

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 3

ER -

Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this